Johnson & Johnson reported sales growth for the DePuy Synthes orthopedics line in the second quarter.
Here are six key notes from the second quarter financial report:
1. The orthopedics sales worldwide was $2.3 billion, up 1.1 percent from the same period last year. The United States sales hit $1.3 billion — a 3 percent growth — while international sales dropped 1.8 percent to $991 million.
2. Hip sales in the United States grew 2.1 percent to $197 million while international sales jumped 6.3 percent to $152 million. Worldwide hip sales hit $349 million — a 3.9 percent increase.
3. Knee sales saw a slight increase — 3.5 percent — worldwide to hit $385 million. In the United States, knee sales were up 3.2 percent to $229 million and international sales were up 4 percent to $156 million.
4. Spine and other sales were $985 million worldwide, a 1.6 percent drop driven by a 4 percent drop in international sales. Spine and other sales in the United States were up 0.4 percent to $557 million.
5. Trauma sales dropped 5.6 percent worldwide, hitting only $255 million. However, trauma sales were up 8.5 percent in the United States to $381 million and showed a 2.4 percent growth overall to $637 million.
6. The company also reported six month results:
• Hip sales: $691 million, 3.3 percent growth
• Knee sales: $774 million, 3.5 percent growth
• Trauma sales: $1.2 billion, 0.1 percent growth
• Spine and other sales: $1.2 billion, 0.1 percent growth